OK Biotech Co., Ltd. (4155) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for OK Biotech Co., Ltd. (4155:TWSE), powered by AI.

Current Price
$15.30
Sector
Healthcare
What is the OK Biotech Co., Ltd. stock price forecast?

OK Biotech Co., Ltd. is currently trading at $15.30. View real-time AI analysis on Alpha Lenz.

What is OK Biotech Co., Ltd. insider trading activity?

View the latest insider trading data for OK Biotech Co., Ltd. on Alpha Lenz.

What is OK Biotech Co., Ltd.'s P/E ratio?

View OK Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.

OK Biotech Co., Ltd.

TWSE · 4155
NT$15.30+0.30(+2.00%)
Ask about OK Biotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

OK Biotech Co., Ltd.'s ROE is 3.3%. Explore profitability and growth together.

Ask for details

Company Overview

OK Biotech Co., Ltd. is a healthcare and biotechnology company that specializes in the development, manufacturing, and distribution of medical devices, particularly focusing on glucose monitoring systems. Its primary purpose is to provide innovative solutions for diabetes management, offering products that help improve the quality of care for diabetic patients. The company's product line includes blood glucose meters, test strips, and continuous glucose monitoring systems, which are essential tools for individuals managing diabetes. OK Biotech impacts both the healthcare and technology sectors by integrating advanced biotechnological research with practical applications for everyday health management. It serves hospitals, healthcare providers, and individual customers by ensuring accessibility to reliable and accurate glucose monitoring technologies. Further, the company emphasizes research and development, often collaborating with global health organizations to stay at the forefront of diabetes management solutions. In the financial market, OK Biotech Co., Ltd. represents a key player in the medical devices and diagnostics space, contributing to the broader healthcare sector's growth. By focusing on diabetic care, the company plays a vital role in addressing one of the most prevalent chronic health conditions globally.

SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.56BRevenue
0.00Shares Out
0Employees

Margins

27.58%Gross
14.11%EBITDA
7.66%Operating
6.67%Pre-Tax
6.24%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

1.61%Rev 3Yr
0.95%Rev 5Yr
-5.27%Op Inc 3Yr
-1.48%Op Inc 5Yr
-10.77%Net Inc 3Yr
-4.35%Net Inc 5Yr

Returns

2.57%ROA
3.29%ROE
3.04%ROIC

Financial Health

NT$314.47MCash & Cash Equivalents
NT$958.84MNet Debt
49.43%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

OK Biotech Co., Ltd. (ticker: 4155) is a company listed on TWSE in the Healthcare sector (Medical Devices).

The current price is 15.3 with a P/E ratio of -x and P/B of -x.

ROE is 3.29% and operating margin is 7.66%. Annual revenue is $1.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
OK Biotech Co., Ltd. (4155) Stock Forecast 2026 $15.30 — Price, Financials & Analyst Targets | Alpha Lenz